sperimentazione

Finally Good news for the Huntington's community!

We received yesterday the official communication from uniQure, announcing that the enrollment of the first patient cohort in the study of ATM-130 for the treatment of Huntington's disease has concluded, ahead of schedule.

But the good news don't end here: a new clinical trial with AMT-130 will be initiated in Europe by the end of the year.